Korean J Gastroenterol.  1999 Sep;34(3):381-389.

Comparison of Efficacy of Midazolam, Ketamine, and Combined Premedication for Endoscopic Retrograde Cholangiopancreatography

Abstract

BACKGROUND/AIMS: For prernedication of endoscopic retrograde cholangiopancreatography (ERCP), midazolam has been widely used. Combined effects of midazolam and ketamine have been reported to bring a good result in some operative cases. We evaluated the efficacy of the combined low dose administration of midazolam and ketamine as premedication for ERCP.
METHODS
Forty-three patients were divided into three groups: ketamine (K), midazolam (M), and combined group (MK). Blood pressure (BP), pulse rate (PR), electrocardiogram and O2 saturation (SaO2) were monitored. We accessed the patients level of consciousness, conditions, tolerance and satisfaction.
RESULTS
BP was significantly elevated after procedure in all groups. PR was not changed but SaO2 was slightly increased in K group. In M group, PR was significantly increased but SaO was not changed. However, all were not changed in MK group. K group was more deeply sedated than others. Significant difference was not noted among three groups in aspect of tolerance and easiness to patients during procedure with tendency to refusal for re-examination in K group. One case of PVC and two of paradoxical agitation were occurred in M group, and one of bradycardia was observed in K group.
CONCLUSIONS
Combined administration of low dose ketamine and midazolam is an effective premedication for ERCP.

Keyword

Midazolam; Ketamine; Combined premedication; ERCP

MeSH Terms

Blood Pressure
Bradycardia
Cholangiopancreatography, Endoscopic Retrograde*
Consciousness
Dihydroergotamine
Disulfiram
Electrocardiography
Heart Rate
Humans
Ketamine*
Midazolam*
Premedication*
Dihydroergotamine
Disulfiram
Ketamine
Midazolam
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr